198 related articles for article (PubMed ID: 11015413)
1. Evaluation of Etest for susceptibility testing of Mycobacterium tuberculosis.
Joloba ML; Bajaksouzian S; Jacobs MR
J Clin Microbiol; 2000 Oct; 38(10):3834-6. PubMed ID: 11015413
[TBL] [Abstract][Full Text] [Related]
2. Testing of Mycobacterium tuberculosis susceptibility to ethambutol, isoniazid, rifampin, and streptomycin by using Etest.
Wanger A; Mills K
J Clin Microbiol; 1996 Jul; 34(7):1672-6. PubMed ID: 8784567
[TBL] [Abstract][Full Text] [Related]
3. E-test: an alternative method for susceptibility testing of Mycobacterium tuberculosis.
Akcali S; Cicek C; Surucuoglu S; Ozbakkaloglu B
Med Princ Pract; 2005; 14(4):264-7. PubMed ID: 15961938
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric testing of susceptibilities of Mycobacterium tuberculosis isolates to ethambutol, isoniazid, and rifampin in 24 hours.
Kirk SM; Schell RF; Moore AV; Callister SM; Mazurek GH
J Clin Microbiol; 1998 Jun; 36(6):1568-73. PubMed ID: 9620378
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the fully automated Bactec MGIT 960 system for the susceptibility testing of Mycobacterium tuberculosis to first-line drugs: a multicenter study.
Kontos F; Maniati M; Costopoulos C; Gitti Z; Nicolaou S; Petinaki E; Anagnostou S; Tselentis I; Maniatis AN
J Microbiol Methods; 2004 Feb; 56(2):291-4. PubMed ID: 14744458
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the ESP culture system II for testing susceptibilities of Mycobacterium tuberculosis isolates to four primary antituberculous drugs.
Bergmann JS; Woods GL
J Clin Microbiol; 1998 Oct; 36(10):2940-3. PubMed ID: 9738047
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the E-test and proportion methods for susceptibility testing of Mycobacterium tuberculosis.
Sanic A; Gunaydin M; Coban AY; Tokac ; Cetin M
J Chemother; 2000 Dec; 12(6):491-4. PubMed ID: 11154031
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the BBL MGIT (Mycobacterial growth indicator tube) AST SIRE system for antimycobacterial susceptibility testing of Mycobacterium tuberculosis to 4 primary antituberculous drugs.
Bergmann JS; Fish G; Woods GL
Arch Pathol Lab Med; 2000 Jan; 124(1):82-6. PubMed ID: 10629136
[TBL] [Abstract][Full Text] [Related]
9. A novel agar base medium for drug susceptibility testing of
Coban AY
Future Microbiol; 2021 Sep; 16():949-953. PubMed ID: 34384261
[No Abstract] [Full Text] [Related]
10. A rapid drug susceptibility test for Mycobacterium tuberculosis using the hybridization protection assay.
Koga H; Miyamoto J; Ohno H; Ogawa K; Tomono K; Tashiro T; Kohno S
J Antimicrob Chemother; 1997 Aug; 40(2):189-94. PubMed ID: 9301983
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a bacteriophage-based assay (phage amplified biologically assay) as a rapid screen for resistance to isoniazid, ethambutol, streptomycin, pyrazinamide, and ciprofloxacin among clinical isolates of Mycobacterium tuberculosis.
Eltringham IJ; Wilson SM; Drobniewski FA
J Clin Microbiol; 1999 Nov; 37(11):3528-32. PubMed ID: 10523547
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of E-test strips for testing susceptibility of Mycobacterium tuberculosis complex strains.
Esteban J; Ortiz A; Jiménez MS
Eur J Clin Microbiol Infect Dis; 2005 Dec; 24(12):856-7. PubMed ID: 16315010
[No Abstract] [Full Text] [Related]
13. [Testing Mycobacterium tuberculosis for drug sensitivity using different methods].
Skriagina EM; Zalutskaia OM; Roth A; Mauch H; Nikolenko EN
Probl Tuberk; 2001; (5):43-5. PubMed ID: 11588962
[TBL] [Abstract][Full Text] [Related]
14. Lack of correlation between embB mutation and ethambutol MIC in Mycobacterium tuberculosis clinical isolates from China.
Shi R; Zhang J; Otomo K; Zhang G; Sugawara I
Antimicrob Agents Chemother; 2007 Dec; 51(12):4515-7. PubMed ID: 17846128
[TBL] [Abstract][Full Text] [Related]
15. Comparison of line probe assay to BACTEC MGIT 960 system for susceptibility testing of first and second-line anti-tuberculosis drugs in a referral laboratory in South Africa.
Maningi NE; Malinga LA; Antiabong JF; Lekalakala RM; Mbelle NM
BMC Infect Dis; 2017 Dec; 17(1):795. PubMed ID: 29282012
[TBL] [Abstract][Full Text] [Related]
16. [Molecular mechanisms of drug resistance of Mycobacterium tuberculosis].
Stepanshin IuG; Stepanshina VN; Shemiakin IG
Antibiot Khimioter; 1999; 44(4):39-43. PubMed ID: 10483496
[No Abstract] [Full Text] [Related]
17. Evaluation of the MB/BacT mycobacterium detection system for susceptibility testing of Mycobacterium tuberculosis.
Díaz-Infantes MS; Ruiz-Serrano MJ; Martínez-Sánchez L; Ortega A; Bouza E
J Clin Microbiol; 2000 May; 38(5):1988-9. PubMed ID: 10790136
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of ciprofloxacin in combination with standard antituberculous drugs against mycobacterium tuberculosis.
Uttley AH; Collins CH
Tubercle; 1988 Sep; 69(3):193-5. PubMed ID: 3151140
[TBL] [Abstract][Full Text] [Related]
19. Colorimetric method for determining MICs of antimicrobial agents for Mycobacterium tuberculosis.
Yajko DM; Madej JJ; Lancaster MV; Sanders CA; Cawthon VL; Gee B; Babst A; Hadley WK
J Clin Microbiol; 1995 Sep; 33(9):2324-7. PubMed ID: 7494021
[TBL] [Abstract][Full Text] [Related]
20. Use of whole-genome sequencing to predict Mycobacterium tuberculosis drug resistance in Shanghai, China.
Wu X; Gao R; Shen X; Guo Y; Yang J; Wu Z; Tan G; Wang H; Yu F
Int J Infect Dis; 2020 Jul; 96():48-53. PubMed ID: 32339720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
